We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.29B
1-Year Est. Return 4.86%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
-4.86%
3 Year Est. Return
+64.44%
5 Year Est. Return
+96.88%
10 Year Est. Return
+353.21%
AUM
$2.94B
AUM Growth
+$171M
Cap. Flow
-$9.19M
Cap. Flow %
-0.31%
Top 10 Hldgs %
68.26%
Holding
686
New
394
Increased
226
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.34M
2
VZ icon
Verizon
VZ
+$1.06M
3
MMP
Magellan Midstream Partners, L.P.
MMP
+$757K
4
SCCO icon
Southern Copper
SCCO
+$748K
5
EPD icon
Enterprise Products Partners
EPD
+$628K

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$22.6M
2
UNP icon
Union Pacific
UNP
+$816K
3
TGT icon
Target
TGT
+$739K
4
DOC icon
Healthpeak Properties
DOC
+$404K
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$137K

Sector Composition

Rank Sector Weight
1 Healthcare 51.92%
2 Energy 8.79%
3 Technology 8.39%
4 Utilities 7.86%
5 Industrials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
301
Cigna
CI
$74.1B
$10K ﹤0.01%
+35
New +$9.11K
KLAC icon
302
KLA
KLAC
$219B
$10K ﹤0.01%
+200
New +$8.36K
PFGC icon
303
Performance Food Group
PFGC
$14.3B
$10K ﹤0.01%
+164
New +$9.66K
RJF icon
304
Raymond James Financial
RJF
$31.7B
$10K ﹤0.01%
+94
New +$8.73K
SLNO
305
DELISTED
Soleno Therapeutics
SLNO
$10K ﹤0.01%
2,288
– –
SM icon
306
SM Energy
SM
$9.08B
$10K ﹤0.01%
+302
New +$8.53K
UNIT
307
Uniti Group
UNIT
$2.32B
$10K ﹤0.01%
2,112
– –
BTI icon
308
British American Tobacco
BTI
$121B
$9K ﹤0.01%
+269
New +$9.2K
DDOG icon
309
Datadog
DDOG
$82.9B
$9K ﹤0.01%
94
– –
DVN icon
310
Devon Energy
DVN
$53.3B
$9K ﹤0.01%
+185
New +$9.3K
ED icon
311
Consolidated Edison
ED
$39B
$9K ﹤0.01%
+100
New +$9.56K
ETN icon
312
Eaton
ETN
$155B
$9K ﹤0.01%
+45
New +$7.92K
GE icon
313
GE Aerospace
GE
$325B
$9K ﹤0.01%
+107
New +$8.66K
MET icon
314
MetLife
MET
$61.8B
$9K ﹤0.01%
+155
New +$8.6K
UBS icon
315
UBS Group
UBS
$154B
$9K ﹤0.01%
+463
New +$9.31K
BRKR icon
316
Bruker
BRKR
$9.24B
$8K ﹤0.01%
+110
New +$8.38K
DOCN icon
317
DigitalOcean
DOCN
$14.6B
$8K ﹤0.01%
199
– –
EQIX icon
318
Equinix
EQIX
$100B
$8K ﹤0.01%
+10
New +$7.32K
HSBC icon
319
HSBC
HSBC
$345B
$8K ﹤0.01%
+201
New +$7.5K
KHC icon
320
The Kraft Heinz Company
KHC
$29.3B
$8K ﹤0.01%
221
+35
+19% +$1.35K
LKQ icon
321
LKQ Corp
LKQ
$5.82B
$8K ﹤0.01%
+135
New +$7.51K
MLKN icon
322
MillerKnoll
MLKN
$1.44B
$8K ﹤0.01%
549
+6
+1% +$96
NGVT icon
323
Ingevity
NGVT
$2.35B
$8K ﹤0.01%
+141
New +$8.46K
NVS icon
324
Novartis
NVS
$264B
$8K ﹤0.01%
+79
New +$7.9K
ONTO icon
325
Onto Innovation
ONTO
$12B
$8K ﹤0.01%
+72
New +$6.87K
11 12
13
14 15

Similar funds

VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OCM
Oribel Capital Management New York $3.29B AUM 83.82% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.3B AUM 0.25% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $3.3B AUM 16.21% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Bollard Group's Q2 2023 Portfolio in Review

As of Q2 2023, Bollard Group held 686 positions worth $2.94B, up 6.2% from $2.77B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Bollard Group's Q2 2023 filing shows 394 new, 226 increased, 9 reduced and 3 closed positions. Its largest new stake was Charles Schwab: 25,625 shares worth $1.45M. The largest sale was Boston Scientific, an estimated $22.6M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 51% a quarter earlier, followed by Energy and Technology.

  • Bollard Group's largest Q2 2023 buy was Charles Schwab: 25,625 shares worth $1.45M.
  • Bollard Group added most to Verizon in Q2 2023, an estimated $1.06M increase.
  • Bollard Group's biggest Q2 2023 reduction was Boston Scientific, cutting an estimated $22.6M.
  • Bollard Group fully exited Cenovus Energy in Q2 2023, selling an estimated $17.
  • Bollard Group's ten largest holdings make up 68% of its $2.94B portfolio in Q2 2023.
  • Bollard Group opened 394 new positions and closed 3 in Q2 2023.
  • Bollard Group's portfolio value rose 6.2% quarter-over-quarter to $2.94B.

Based on Bollard Group's 13F filing for Q2 2023, filed 14 Aug 2023.